Emeritus Research   Report issue

For profit Phase 1 Phase 2
Founded: Melbourne Australia (2020)

Organization Overview

First Clinical Trial
2020
NCT04153409
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Emeritus Research